Nanotechnology Now

Our NanoNews Digest Sponsors

Heifer International

Wikipedia Affiliate Button

Home > Press > NanoImaging Services Relocates to Larger Facility in La Jolla, Calif.

Abstract:
Biopharmaceutical analytical services company expands into a 2,500 square-foot laboratory and adds staff to accommodate growing business

NanoImaging Services Relocates to Larger Facility in La Jolla, Calif.

San Diego, CA | Posted on March 22nd, 2008

NanoImaging Services, Inc., the leading provider of high-resolution, three-dimensional (3D) transmission electron microscope (TEM) imaging services to manufacturers of large molecule biopharmaceuticals, announced today that it has moved to a larger facility in La Jolla, Calif. The new 2,500-square-foot facility will enable NanoImaging Services to expand the capacity of its service laboratory and add new employees in an effort to accommodate its growing biopharmaceutical client base.

"By allowing researchers to actually see the nano scale structures they are working with, we help them improve speed and reduce risk in all phases of the drug development process, from discovery and characterization through approval and manufacturing," said Clint Potter, CEO, NanoImaging Services. "This new facility will allow us to meet the rapidly growing demand we have seen already in our first four months of operation."

NanoImaging benefited from early support and funding from Merck Capital Ventures, LLC, a subsidiary of Merck & Co., Inc., and FEI Company. The company's new location is 10931 North Torrey Pines Road, # 108, San Diego, CA 92037 USA. For more information, please visit www.nanoimagingservices.com.

####

About NanoImaging Services, Inc.
NanoImaging Services, Inc. provides transmission electron microscope imaging services to the pharmaceutical, biotechnology and nanotechnology industries, and specializes in the characterization of large biological molecules used in biopharmaceuticals such as vaccines, antibodies, cytokines, hormones and gene therapies. In contrast to conventional (small molecule) drugs, biopharmaceuticals are typically protein-based and manufactured in controlled, modified, biological systems. Their complexity and similarity to naturally occurring compounds makes a detailed understanding of their structure, and its relationship to their safety and efficacy, essential in their development and approval. Biopharmaceuticals represent an important and rapidly-growing segment of the pharmaceutical industry.

For more information, please click here

Contacts:
Clint Potter
NanoImaging Services, Inc.
888-675-8261


Sandy Fewkes
MindWrite Communications, Inc.
408-224-4024

Copyright © NanoImaging Services, Inc.

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Bookmark:
Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related News Press

News and information

Searching for errors in the quantum world September 21st, 2018

Viral RNA sensing: Optical detection of picomolar concentrations of RNA using switches in plasmonic chirality September 21st, 2018

UT engineers develop first method for controlling nanomotors: Breakthrough for nanotechnology as UT engineers develop first method for switching the mechanical motion of nanomotors September 21st, 2018

Nanobiotix: Update on Head and Neck Phase I/II Trial with NBTXR3 and Other program data presented at ImmunoRad 2018 September 20th, 2018

Imaging

Viral RNA sensing: Optical detection of picomolar concentrations of RNA using switches in plasmonic chirality September 21st, 2018

Openings/New facilities/Groundbreaking/Expansion

NanoBio Announces Corporate Name Change to BlueWillow Biologics and Closes $10M Series A Financing: Move Reflects Focus on Advancing Several Intranasal Vaccines to Human Studies May 9th, 2018

Aculon Expands NanoProof® Product Line for Electronics Waterproofing Technology: With growing market opportunities Aculon Launches NanoProof® 8 with Push Through Connectivity™ and NanoProof® DAB a syringe application May 30th, 2017

GLOBALFOUNDRIES and Chengdu Partner to Expand FD-SOI Ecosystem in China: More than $100M investment to establish a center of excellence for FDXTM FD-SOI design May 23rd, 2017

GLOBALFOUNDRIES Expands to Meet Worldwide Customer Demand: Company invests for capacity growth in the United States, Germany, China and Singapore February 10th, 2017

Announcements

Searching for errors in the quantum world September 21st, 2018

Viral RNA sensing: Optical detection of picomolar concentrations of RNA using switches in plasmonic chirality September 21st, 2018

UT engineers develop first method for controlling nanomotors: Breakthrough for nanotechnology as UT engineers develop first method for switching the mechanical motion of nanomotors September 21st, 2018

Nanobiotix: Update on Head and Neck Phase I/II Trial with NBTXR3 and Other program data presented at ImmunoRad 2018 September 20th, 2018

NanoNews-Digest
The latest news from around the world, FREE



  Premium Products
NanoNews-Custom
Only the news you want to read!
 Learn More
NanoStrategies
Full-service, expert consulting
 Learn More











ASP
Nanotechnology Now Featured Books




NNN

The Hunger Project